Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 99
of 5Next
1:

Investment in online self-evaluation tests: A theoretical approach.

de Gara F, Gallo WT, Bisson JI, Endrass J, Vetter S.

J Trauma Manag Outcomes. 2008 Apr 15;2:3.

PMID: 18412943 [PubMed - in process]

2:

Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.

Hersh WR, Wallace JA, Patterson PK, Shapiro SE, Kraemer DF, Eilers GM, Chan BK, Greenlick MR, Helfand M.

Evid Rep Technol Assess (Summ). 2001 Aug;(24 Suppl):1-32.

PMID: 11569328 [PubMed - indexed for MEDLINE]

3:

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation]

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID: 15959450 [PubMed - indexed for MEDLINE]

4:

Cost-benefit analysis of drug treatment services: review of the literature*

Cartwright WS.

J Ment Health Policy Econ. 2000 Mar 1;3(1):11-26.

PMID: 11967433 [PubMed - as supplied by publisher]

5:

The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation.

Burr JM, Mowatt G, Hernández R, Siddiqui MA, Cook J, Lourenco T, Ramsay C, Vale L, Fraser C, Azuara-Blanco A, Deeks J, Cairns J, Wormald R, McPherson S, Rabindranath K, Grant A.

Health Technol Assess. 2007 Oct;11(41):iii-iv, ix-x, 1-190. Review.

PMID: 17927922 [PubMed - indexed for MEDLINE]

6:

Antidepressant treatment for depression: total charges and therapy duration*

Dobrez DG, Melfi CA, Croghan TW, Kniesner TJ, Obenchain RL.

J Ment Health Policy Econ. 2000 Dec 1;3(4):187-197.

PMID: 11967455 [PubMed - as supplied by publisher]

7:

[Polish Multicenter Study on Diabetes Epidemiology (PMSDE)--1998-2000]

Szybiński Z.

Pol Arch Med Wewn. 2001 Sep;106(3):751-8. Polish.

PMID: 11928582 [PubMed - indexed for MEDLINE]

8:

How to develop cost-conscious guidelines.

Eccles M, Mason J.

Health Technol Assess. 2001;5(16):1-69. Review.

PMID: 11427188 [PubMed - indexed for MEDLINE]

9:

Economic evaluation and mental health: sparse past. fertile future?

Knapp M.

J Ment Health Policy Econ. 1999 Dec 1;2(4):163-167.

PMID: 11967427 [PubMed - as supplied by publisher]

10:

Developments in the screening for Chlamydia trachomatis: a review.

Kohl KS, Markowitz LE, Koumans EH.

Obstet Gynecol Clin North Am. 2003 Dec;30(4):637-58. Review.

PMID: 14719842 [PubMed - indexed for MEDLINE]

11:

Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.

Connock M, Juarez-Garcia A, Jowett S, Frew E, Liu Z, Taylor RJ, Fry-Smith A, Day E, Lintzeris N, Roberts T, Burls A, Taylor RS.

Health Technol Assess. 2007 Mar;11(9):1-171, iii-iv. Review.

PMID: 17313907 [PubMed - indexed for MEDLINE]

12:

[Evaluation of the burden of diabetes in Poland]

Kissimova-Skarbek K, Pach D, Płaczkiewicz E, Szurkowska M, Szybiński Z.

Pol Arch Med Wewn. 2001 Sep;106(3):867-73. Polish.

PMID: 11928598 [PubMed - indexed for MEDLINE]

13:

Evaluation of costs and benefits of advances in cytologic technology. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.

Melamed MR, Hutchinson ML, Kaufman EA, Schechter CB, Garner D, Kobler TP, Krieger PA, Reith A, Schenck U.

Acta Cytol. 1998 Jan-Feb;42(1):69-75. Review.

PMID: 9479325 [PubMed - indexed for MEDLINE]

14:

The public sector and mental health parity: time for inclusion.

Hogan MF.

J Ment Health Policy Econ. 1998 Dec 1;1(4):189-198.

PMID: 11967396 [PubMed - as supplied by publisher]

15:

Acceptability, benefit and costs of early screening for hearing disability: a study of potential screening tests and models.

Davis A, Smith P, Ferguson M, Stephens D, Gianopoulos I.

Health Technol Assess. 2007 Oct;11(42):1-294.

PMID: 17927921 [PubMed - indexed for MEDLINE]

16:

Costs of nine common mental disorders: implications for curative and preventive psychiatry.

Smit F, Cuijpers P, Oostenbrink J, Batelaan N, de Graaf R, Beekman A.

J Ment Health Policy Econ. 2006 Dec;9(4):193-200.

PMID: 17200596 [PubMed - indexed for MEDLINE]

17:

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID: 15099124 [PubMed - indexed for MEDLINE]

18:

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.

Forbes C, Shirran L, Bagnall AM, Duffy S, ter Riet G.

Health Technol Assess. 2001;5(28):1-110. Review.

PMID: 11701100 [PubMed - indexed for MEDLINE]

19:

The cost of schizophrenia: lessons from an international comparison.

Blomqvist AG, Léger PT, Hoch JS.

J Ment Health Policy Econ. 2006 Dec;9(4):177-83.

PMID: 17200594 [PubMed - indexed for MEDLINE]

20:

Cost of depression in Europe.

Sobocki P, Jönsson B, Angst J, Rehnberg C.

J Ment Health Policy Econ. 2006 Jun;9(2):87-98.

PMID: 17007486 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 99
of 5Next